Frequency of bone densitometry for osteoporosis?
Kleerekoper
M
M
Wayne State University, Detroit, USA.
D015502:Absorptiometry, Photon; D019386:Alendronate / Q000008:administration & dosage / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000378:metabolism; D002116:Calcitonin / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013997:Time Factors
D015415:Biomarkers; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D002116:Calcitonin; D019386:Alendronate